Table 2:
Trial Demographics by Treatment Group
| Demographic | Placebo (N=22) | 1.5 mg/kg rhCC10 (N=22) | Placebo (N=21) | 5 mg/kg rhCC10 (N=23) |
|---|---|---|---|---|
| Region – N (%) US Poland |
22 (100) N/A |
22 (100) N/A |
10 (48) 11 (52) |
11 (48) 12 (52) |
| White - N (%) | 9 (41) | 12 (55) | 15 (71) | 18 (78) |
| Hispanic ethnicity – N (%) | 5 (23) | 7 (32) | 5 (24) | 5 (22) |
| Female – N (%) | 12 (55) | 8 (36) | 8 (38) | 12 (52) |
| Mean gestational age at birth (SD) – weeks | 26.1 (1.3) | 26.5 (1.1) | 27.0 (1.3) | 26.6 (1.2) |
| Mean birth weight (SD) – grams | 877.4 (170.9) | 859.3 (140.9) | 885.5 (173.9) | 867.2 (187.2) |
| Median 5 minute APGAR score (IQR) | 8 (7, 8) | 7 (6, 8) | 7 (7, 8) | 7 (6, 8) |
SD – Standard Deviation; IQR – Interquartile Range; N/A – not applicable